Contiguous Stage II Marginal Zone Lymphoma Active Not Recruiting Phase 2 Trials for Fludarabine (DB01073)

Back to Contiguous Stage II Marginal Zone Lymphoma
IndicationStatusPhase
DBCOND0029471 (Contiguous Stage II Marginal Zone Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00040846Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesTreatment
NCT00089011Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerTreatment